Russell Investments Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Buy
56,882
+44,457
+358% +$192K ﹤0.01% 2983
2026
Q1
$48.1K Sell
12,425
-83
-0.7% -$341 ﹤0.01% 3341
2025
Q4
$52.3K Buy
12,508
+83
+0.7% +$321 ﹤0.01% 3287
2025
Q3
$40.9K Buy
+12,425
New +$35.1K ﹤0.01% 3358
2023
Q3
Sell
-16,556
Closed -$19K 3605
2023
Q2
$19K Hold
16,556
﹤0.01% 2847
2023
Q1
$17.5K Buy
+16,556
New +$23.9K ﹤0.01% 2829
2020
Q1
Sell
-65,736
Closed -$359K 3111
2019
Q4
$359K Buy
+65,736
New +$370K ﹤0.01% 2516
2018
Q1
Sell
-72
Closed -$1K 2976
2017
Q4
$1K Hold
72
﹤0.01% 2946
2017
Q3
$1K Hold
72
﹤0.01% 2929
2017
Q2
$2K Sell
72
-1,716
-96% -$37.6K ﹤0.01% 2948
2017
Q1
$35K Sell
1,788
-223
-11% -$4.98K ﹤0.01% 2936
2016
Q4
$50K Buy
+2,011
New +$56K ﹤0.01% 2979

Other funds holding PGEN

Russell Investments Group's PGEN Position: Q2 2026 in Review

Russell Investments Group increased its Precigen (PGEN) stake by 358% in Q2 2026, buying an estimated $192K and bringing the position to 56,882 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

Russell Investments Group first reported a position in PGEN in Q4 2016 and has held it in 12 quarters since. The position peaked at $359K in Q4 2019. 74 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Russell Investments Group held 56,882 shares of Precigen worth $324K as of Q2 2026.
  • Russell Investments Group bought 44,457 Precigen shares in Q2 2026, an estimated $192K.
  • Precigen made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2983 holding.
  • Russell Investments Group first reported a position in Precigen in Q4 2016 and has held it in 12 quarters since.
  • Russell Investments Group's Precigen position peaked at $359K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.